Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience (Q39726002)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 March 2010
edit
Language Label Description Also known as
English
Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
scientific article published on 18 March 2010

    Statements

    Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience (English)
    Ari Zimran
    Mici Philips
    Drorit Attias
    Marina Jmoudiak
    Maher Deeb
    Nan Wang
    Kiran Bhirangi
    Gabriel M Cohn
    Deborah Elstein
    18 March 2010
    4651-4656

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit